Navigation Links
Gene Mutation Suggests New Treatment Target for Specific Lymphoma
Date:12/22/2010

WEDNESDAY, Dec. 22 (HealthDay News) -- Researchers have identified a gene mutation that may offer a target for new treatments for a type of lymphoma.

The team found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as large B cell lymphoma.

The MYD88 gene encodes a protein that is crucial for normal immune response to invading microorganisms. The mutation identified in this study can cause uncontrolled cellular signaling, resulting in the survival of malignant cells.

A subgroup of the large B cell lymphoma that has a dismally low cure rate -- known as the activated B cell-like (ABC) subtype -- appears particularly susceptible to the gene.

Lymphoma is a cancer of the blood that starts in white blood cells. Diffuse large B cell lymphoma, in turn, is a type of non-Hodgkin lymphoma, in which white blood cells known as lymphocytes multiply out of control. There are three subtypes of diffuse large cell lymphoma: Patients with the ABC form have the lowest rate of three-year survival, with only 40 percent reaching that milestone.

The researchers, led by scientists at the U.S. National Cancer Institute (NCI), found that the mutant form of MYD88 allowed the ABC lymphoma cells to survive but the non-mutated version did not.

One more piece of the puzzle was unraveled through another cell-signalling protein called IRAK4. The researchers found it functioned as an enzyme to modify a substance called IRAK1, which was required for the mutant MYD88 protein to promote lymphoma cell survival.

"We believe the results of this study may provide a method to identify patients with the [ABC subtype] whose tumors may depend upon MYD88 signaling," study author Louis M. Staudt, of NCI's Center for Cancer Research, said in an NCI news release.

These patients, he said, may thus benefit from therapies targeting "regulatory pathways that sustain the survival of these lymphoma cells."

The study appears online Dec. 22 in the journal Nature.

More information

The American Cancer Society has more about non-Hodgkin lymphoma.

-- Robert Preidt

SOURCE: U.S. National Cancer Institute, news release, Dec. 22, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Single gene mutation induces endometrial cancer
2. Genetic Mutation Linked to Prostate Cancer in Blacks
3. Gene Mutations Identified for Charcot-Marie-Tooth Syndrome
4. Study shows that mutations in 1 gene cause many cancers
5. Parkinsons Linked to Genetic Mutation
6. Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast
7. Gene Mutations Up Risk for Cancer in Opposite Breast
8. Gene Mutation Ups Risk of Sudden Death in People with Epilepsy
9. Heart Disease Among Childhood Cancer Survivors Tied to Gene Mutations
10. New research indicates that DNA sequence itself influences mutation rate
11. Single Lung Tumor Contains 50,000 Mutations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Mutation Suggests New Treatment Target for Specific Lymphoma
(Date:4/30/2017)... San Francisco, CA (PRWEB) , ... April 30, 2017 , ... ... Bay Area, is proud to announce an updated blog post on the continual issue ... are "too busy" to seek a second opinion before dental surgery, but this can ...
(Date:4/29/2017)... ... April 29, 2017 , ... Natural Family Planning ... observe the naturally occurring signs and symptoms of a woman's menstrual cycle. ... , Natural family planning and fertility are special interests of Dr. Bazger’s. She ...
(Date:4/29/2017)... UTAH (PRWEB) , ... April 29, 2017 , ... Phytomer ... region. As a Phytomer Account Manager, Smith’s role is to provide excellent ... brands that make up The Phytomer Group. Smith comes to Phytomer with a wealth ...
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... More than ... so what are Americans doing in their leisure time that causes hearing loss? May ... habits that may be contributing to hearing loss, as well as schedule a hearing ...
(Date:4/28/2017)... , ... April 28, 2017 , ... An April 24th article on Yahoo! ... 180 pounds with the help of a weight loss surgery. The woman, declaring “I will ... that have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 The ... anticipated to showcase a healthy CAGR during the forecast period ... product type in the global digital mobile X-Ray devices market, ... 2,000 Mn in 2017, expanding at a CAGR of 7% ... create absolute $ opportunity of more than US$ 100 Mn ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: